Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
D000328:Adult; D018692:Antimanic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001569:Benzodiazepines; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000150:complications*; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000209:etiology*; D014635:Valproic Acid / Q000008:administration & dosage* / Q000627:therapeutic use*
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D014635:Valproic Acid; D000077152:Olanzapine